A Comparative Study of KHK6188

NCT01544296 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Postherpetic Neuralgia

Interventions

DRUG: KHK6188
DRUG: Placebo

Sponsor

Kyowa Kirin Co., Ltd.